Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stuart A Sievers

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Nature|June 17, 2011
Structure-based design of non-natural amino-acid inhibitors of amyloid fibril formationStuart A Sievers, John Karanicolas, Howard W Chang, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 18, 2013
Aggregation-triggering segments of SOD1 fibril formation support a common pathway for familial and sporadic ALSMagdalena I Ivanova, Stuart A Sievers, Elizabeth L Guenther, et al.
Journal of the American Chemical Society|December 5, 2014
Structure-based design of functional amyloid materialsDan Li, Eric M Jones, Michael R Sawaya, et al.
Elife|March 22, 2016
Structural basis for germline antibody recognition of HIV-1 immunogensLouise Scharf, Anthony P West, Stuart A Sievers, et al.
JCI Insight|June 3, 2020
Activation of CAR and non-CAR T cells within the tumor microenvironment following CAR T cell therapyPei-Hsuan Chen, Mikel Lipschitz, Jason L Weirather, et al.
Cancer Letters|August 29, 2006
The TCL1 oncoprotein binds the RNase PH domains of the PNPase exoribonuclease without affecting its RNA degrading activitySamuel W French, David W Dawson, Hsiao-Wen Chen, et al.
Nature|May 1, 2007
Atomic structures of amyloid cross-beta spines reveal varied steric zippersMichael R Sawaya, Shilpa Sambashivan, Rebecca Nelson, et al.
Plos Pathogens|October 31, 2015
A New Glycan-Dependent CD4-Binding Site Neutralizing Antibody Exerts Pressure on HIV-1 In VivoNatalia T Freund, Joshua A Horwitz, Lilian Nogueira, et al.
Science Translational Medicine|January 20, 2017
Coexistence of potent HIV-1 broadly neutralizing antibodies and antibody-sensitive viruses in a viremic controllerNatalia T Freund, Haoqing Wang, Louise Scharf, et al.
Science (New York, N.Y.)|June 19, 2025
In vivo CAR T cell generation to treat cancer and autoimmune diseaseTheresa L Hunter, Yanjie Bao, Yan Zhang, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Nature|June 17, 2011
Structure-based design of non-natural amino-acid inhibitors of amyloid fibril formationStuart A Sievers, John Karanicolas, Howard W Chang, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 18, 2013
Aggregation-triggering segments of SOD1 fibril formation support a common pathway for familial and sporadic ALSMagdalena I Ivanova, Stuart A Sievers, Elizabeth L Guenther, et al.
Journal of the American Chemical Society|December 5, 2014
Structure-based design of functional amyloid materialsDan Li, Eric M Jones, Michael R Sawaya, et al.
Elife|March 22, 2016
Structural basis for germline antibody recognition of HIV-1 immunogensLouise Scharf, Anthony P West, Stuart A Sievers, et al.
JCI Insight|June 3, 2020
Activation of CAR and non-CAR T cells within the tumor microenvironment following CAR T cell therapyPei-Hsuan Chen, Mikel Lipschitz, Jason L Weirather, et al.
Cancer Letters|August 29, 2006
The TCL1 oncoprotein binds the RNase PH domains of the PNPase exoribonuclease without affecting its RNA degrading activitySamuel W French, David W Dawson, Hsiao-Wen Chen, et al.
Nature|May 1, 2007
Atomic structures of amyloid cross-beta spines reveal varied steric zippersMichael R Sawaya, Shilpa Sambashivan, Rebecca Nelson, et al.
Plos Pathogens|October 31, 2015
A New Glycan-Dependent CD4-Binding Site Neutralizing Antibody Exerts Pressure on HIV-1 In VivoNatalia T Freund, Joshua A Horwitz, Lilian Nogueira, et al.
Science Translational Medicine|January 20, 2017
Coexistence of potent HIV-1 broadly neutralizing antibodies and antibody-sensitive viruses in a viremic controllerNatalia T Freund, Haoqing Wang, Louise Scharf, et al.
Science (New York, N.Y.)|June 19, 2025
In vivo CAR T cell generation to treat cancer and autoimmune diseaseTheresa L Hunter, Yanjie Bao, Yan Zhang, et al.
Pageof 2